Research grade peptide

This combination pairs two of the most extensively studied peptides in tissue-repair research: BPC-157, a synthetic peptide derived from a protective protein found in human gastric juice, and TB-500, a synthetic fragment of Thymosin Beta-4, a naturally occurring protein present in nearly all human and animal cells. Individually, each peptide has been investigated for distinct but complementary roles in tissue regeneration. Combined, they are one of the most popular research stacks in the peptide field due to their proposed synergistic action across multiple repair pathways — soft tissue, vascular, and cellular.

​

Description

BPC-157 ("Body Protection Compound-157") is a pentadecapeptide (15 amino acids) studied primarily for its potential to accelerate healing in tendons, ligaments, muscle, and the gastrointestinal lining. Research has explored its role in promoting angiogenesis (new blood vessel formation), modulating nitric oxide pathways, and supporting the integrity of the gut-brain axis.

​

TB-500 is a synthetic version of a naturally occurring peptide fragment derived from Thymosin Beta-4. It has been studied for its influence on actin regulation — a protein central to cell structure and movement — which researchers believe underlies its proposed effects on cell migration, wound healing, and reduced inflammation and fibrosis (scar tissue formation) in damaged tissue.

​

Proposed Synergy of the Blend

Research interest in combining these two peptides stems from their complementary — rather than overlapping — mechanisms:

• BPC-157 is theorized to act more locally, concentrating repair signaling at the specific site of tissue damage.

• TB-500 is theorized to act more systemically, supporting cell migration and structural repair across a broader area, including its ability to move through tissue with limited vascularity.

Together, this is proposed in research contexts to support a more comprehensive approach to tissue recovery — addressing both localized injury sites and broader systemic inflammatory or structural repair processes.

​

Research Focus Areas

• Musculoskeletal injury recovery (tendons, ligaments, muscle tissue)

• Joint and connective tissue support

• Inflammation modulation

• Angiogenesis and vascular repair

• Gastrointestinal tissue integrity (primarily attributed to BPC-157)

• Cellular migration and reduced fibrosis (primarily attributed to TB-500)

​​

Status

This blend, like its individual components, remains strictly a research compound and is not approved by the FDA or any regulatory body for human therapeutic use, diagnosis, treatment, or prevention of any disease. It is intended for laboratory and preclinical research purposes only.